Press Releases August 7, 2026 10:51 AM

Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference

Progyny CEO to Present at Canaccord Genuity Annual Growth Conference

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn
PGNY

Progyny, Inc., a leading company in women's health and family building solutions, announced that CEO Pete Anevski will present at the Canaccord Genuity 46th Annual Growth Conference. The presentation will be webcast live and available for replay on the company's investor relations website.

Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference
PGNY
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Progyny is recognized as a leader in women's health benefits, serving employers, health plans, and benefit purchasers.
  • The company offers comprehensive fertility and women's health solutions aimed at improving clinical outcomes and reducing healthcare costs.
  • Progyny has received numerous accolades for growth, innovation, and workplace environment, highlighting its prominence in the healthcare sector.

NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that its CEO Pete Anevski will present at the Canaccord Genuity 46th Annual Growth Conference in Boston, MA on Tuesday, August 11, 2026, at 3:30 p.m. ET.

Live audiocasts and replays of the webcasted session will be available in the Events and Presentations section of Progyny’s investor relations website at http://investors.progyny.com.

About Progyny

Progyny (Nasdaq: PGNY) is a global leader in women's health and family building solutions, trusted by the nation's leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive and intentionally designed solutions simultaneously benefit employers, patients, and physicians.

Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.

Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, INC. 5000, INC. Power Partners and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com.

For Further Information, Please Contact:

Investors:
James Hart
[email protected]

Media:
Alexis Ford
[email protected]


Risks

  • Market reception to the conference presentation is uncertain and may not impact the stock positively.
  • The competitive nature of the healthcare and fertility benefits sector could affect Progyny's future growth.
  • Changes in healthcare regulations and employer benefit priorities could influence the demand for Progyny's services.

More from Press Releases

red violet Announces Closing of $115 Million Underwritten Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option Aug 7, 2026 B2Gold Granted Fekola Regional Exploitation Permit by the State of Mali Aug 7, 2026 Bending Spoons to announce Q2 2026 results Aug 7, 2026 United-Guardian Reports Second Quarter Results Aug 7, 2026 Toll Brothers Announces Final Opportunity to Own a New Luxury Home in Seabrook Village at Nocatee Aug 7, 2026